Novel anti-BMP6 targeted antibody reduces the need for EPO in anemia of chronic disease models Dec. 21, 2018 No Comments
FLT180a gene therapy safe in first two hemophilia B patients in clinical trial Dec. 5, 2018 No Comments
Bayer presents first phase I data for BAY-1093884 in patients with hemophilia Dec. 3, 2018 No Comments
Bayer initiates phase I II study of factor VIII gene transfer therapy with BAY-2599023 Dec. 3, 2018 No Comments
Preclinical evaluation of zifaxaban, an oral inhibitor of factor Xa for thromboembolic diseases Nov. 28, 2018 No Comments
RSS